Research and Development in Biotechnology (except Nanobiotechnology) - Market Size, Financial Statistics, Industry Trends
Industry Overview
This U.S. industry comprises establishments primarily engaged in conducting biotechnology (except nanobiotechnology) research and experimental development. Biotechnology (except nanobiotechnology) research and experimental development involves the study of the use of microorganisms and cellular and biomolecular processes to develop or alter living or non-living materials. This research and development in biotechnology (except nanobiotechnology) may result in development of new biotechnology (except nanobiotechnology) processes or in prototypes of new or genetically-altered products that may be reproduced, utilized, or implemented by various industries. Illustrative Examples: Cloning research and experimental development laboratories DNA technologies (e.g., microarrays) research and experimental development laboratories Nucleic acid chemistry research and experimental development laboratories Protein engineering research and experimental development laboratories Recombinant DNA research and experimental development laboratories Cross-References. Establishments primarily engaged in--Source: U.S. Census Bureau
Research and Development in Biotechnology (except Nanobiotechnology) Market Size
This report includes historical and forecasted market sizes and industry trends for Research and Development in Biotechnology (except Nanobiotechnology). It reveals overall market dynamics from 2020 through the present, and predicts industry growth or shrinkage through 2030. Revenue data include both public and private companies in the Research and Development in Biotechnology (except Nanobiotechnology) industry.| Historical | Forecasted | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | |
| Market Size (Total Revenue) | Included in Report |
||||||||||
| % Growth Rate | |||||||||||
| Number of Companies | |||||||||||
| Total Employees | |||||||||||
| Average Revenue per Company | |||||||||||
| Average Employees per Company | |||||||||||
Industry Revenue ($ Billions)
Industry Forecast ($ Billions)
Pell Research's advanced econometric models forecast five years of industry growth based on short- and long-term trend analysis. Market size statistics include revenue generated from all products and services sold within the Research and Development in Biotechnology (except Nanobiotechnology) industry.
Geographic Breakdown by U.S. State
Research and Development in Biotechnology (except Nanobiotechnology) market share by state pinpoints local opportunities based on regional revenue statistics. Growth rate for each state is affected by regional economic conditions. Data by state can be used to locate profitable and nonprofitable locations for Research and Development in Biotechnology (except Nanobiotechnology) companies in the United States.Industry Revenue by State [Sample]
Distribution by Company Size
| Company Size | All Industries | Research and Development in Biotechnology (except Nanobiotechnology) |
|---|---|---|
| Small Business (< 5 Employees) | Included |
|
| Small Business (5 - 20) | ||
| Midsized Business (20 - 100) | ||
| Large Business (100 - 500) | ||
| Enterprise (> 500) | ||
Industry Income Statement (Average Financial Metrics)
Financial statement analysis determines averages for the following industry forces:- Cost of goods sold
- Compensation of officers
- Salaries and wages
- Employee benefit programs
- Rent paid
- Advertising and marketing budgets
The report includes a traditional income statement from an "average" Research and Development in Biotechnology (except Nanobiotechnology) company (both public and private companies are included).
| Industry Average | Percent of Sales | |
|---|---|---|
| Total Revenue | Included |
|
| Operating Revenue | ||
| Cost of Goods Sold (COGS) | ||
| Gross Profit | ||
| Operating Expenses | ||
| Operating Income | ||
| Non-Operating Income | ||
| Earnings Before Interest and Taxes (EBIT) | ||
| Interest Expense | ||
| Earnings Before Taxes | ||
| Income Tax | ||
| Net Profit | ||
Average Income Statement
Cost of Goods Sold
Salaries, Wages, and Benefits
Rent
Advertising
Depreciation and Amortization
Officer Compensation
Net Income
Financial Ratio Analysis
Financial ratios allow a company's performance to be compared against that of its peers.| Financial Ratio | Industry Average |
|---|---|
| Profitability Ratios | Included |
| Profit Margin | |
| ROE | |
| ROA | |
| Liquidity Ratios | |
| Current Ratio | |
| Quick Ratio | |
| Activity Ratios | |
| Average Collection Period | |
| Asset Turnover Ratio | |
| Receivables Turnover Ratio | |
| Inventory Conversion Ratio |
Compensation and Salary Surveys
Salary information for employees working in the Research and Development in Biotechnology (except Nanobiotechnology) industry.| Title | Percent of Workforce | Bottom Quartile | Average (Median) Salary | Upper Quartile |
|---|---|---|---|---|
| Management Occupations | 14% |
Included |
||
| Chief Executives | 0% | |||
| General and Operations Managers | 2% | |||
| Other Management Occupations | 6% | |||
| Business and Financial Operations Occupations | 10% | |||
| Business Operations Specialists | 8% | |||
| Computer and Mathematical Occupations | 12% | |||
| Computer Occupations | 11% | |||
| Software Developers and Programmers | 5% | |||
| Architecture and Engineering Occupations | 17% | |||
| Engineers | 14% | |||
| Life, Physical, and Social Science Occupations | 25% | |||
| Life Scientists | 12% | |||
| Medical Scientists | 7% | |||
| Medical Scientists, Except Epidemiologists | 7% | |||
| Life, Physical, and Social Science Technicians | 7% | |||
| Office and Administrative Support Occupations | 9% | |||
Top Companies in Research and Development in Biotechnology (except Nanobiotechnology) and Adjacent Industries
| Company | Address | Revenue ($ Millions) |
|---|---|---|
Included |
||